Rift Valley Fever in Kenya
NCT00287014 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2010-08-27
Summary
The purpose of this study is to find out how, why, and when Rift Valley Fever (RVF) spreads. Participants will be 250 adults and children, aged 1 year and older, from the Ijara District, Kenya. They will be given a questionnaire, undergo a medical examination that includes an eye exam, and have a 1-teaspoon sample of blood taken from a vein. Participation will take about 3 hours.
Conditions
- Rift Valley Fever
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-03-31
- Completion
- 2006-04-30
Countries
- Kenya
Study Locations
More Related Trials
-
Implementation and Evaluation of Vector Control Methods in Kinshasa: The Case of Aedes
NCT06981442 ·Status: RECRUITING ·Phase: NA
-
Western Kenya Integrated COVID-19 Response
NCT04501458 ·Status: UNKNOWN ·Phase: NA
-
Development of a New Rapid Diagnostic Test to Support Onchocerciasis Elimination
NCT06350851 ·Status: RECRUITING ·Phase: NA
-
Research for Elimination of Lymphatic Filariasis (ICIDR)
NCT00406627 ·Status: COMPLETED
-
Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis
NCT00146627 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation to Assess the Usability of rK28 for the Diagnosis of Visceral Leishmaniasis in Kenya
NCT05386875 ·Status: UNKNOWN
-
Prospective Evaluation of the Specificity of Serological Tests for Human African Trypanosomiasis
NCT05466630 ·Status: COMPLETED ·Phase: NA
-
Assessment of Recombinant HAT-RDT Specificity
NCT05637632 ·Status: COMPLETED
-
Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy
NCT03052998 ·Status: COMPLETED ·Phase: PHASE4
-
Lymphatic Filariasis (LF) in Ivory Coast
NCT02974049 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness
NCT00127504 ·Status: COMPLETED ·Phase: PHASE2
-
West Nile Virus Natural History
NCT00138463 ·Status: COMPLETED
-
Assessment of Anaemia Attributable to Schistosomiasis in School Children in Kenya: Mechanisms and Effect of Treatment
NCT00414479 ·Status: COMPLETED
-
Evaluation of ACCS100 to Reduce Aflatoxin Exposure in Kenya
NCT02188953 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda
NCT00215267 ·Status: COMPLETED ·Phase: NA
-
Seroprevalence of Leptospirosis in Val Müstair, Switzerland
NCT05300425 ·Status: COMPLETED
-
Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa
NCT04035174 ·Status: WITHDRAWN ·Phase: NA
-
Ivermectin Treatment of Persons With Onchocerciasis-associated Epilepsy
NCT03852303 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana
NCT02078024 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Patients With Active Neurocysticercosis in Eastern Africa
NCT03834337 ·Status: COMPLETED
-
Evaluation of the Use of a Urin Test Strip to Determine the Spread of Schistosoma Infections in Areas Where Schistosomiasis Infections Are Low in Kenya
NCT00463307 ·Status: COMPLETED
-
Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area
NCT05749653 ·Status: COMPLETED ·Phase: NA
-
Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects
NCT05256017 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP3 Post Elimination Monitoring
NCT04099628 ·Status: COMPLETED ·Phase: NA
-
Etiology of Uncomplicated Fever in Children <5 in Rural Zanzibar
NCT01094431 ·Status: COMPLETED